CVS Health Corp vs VanEck Gold Miners ETF — how do they compare? CVS Health Corp trades at $86.2 (market cap $112.49B), while VanEck Gold Miners ETF trades at $88.61 (market cap $25.65B). The key difference: CVS Health Corp is far larger — about 4.4× VanEck Gold Miners ETF's market cap, and CVS Health Corp pays a 3.02% dividend while VanEck Gold Miners ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and VanEck Gold Miners ETF for 76 Days on average.
| CVS | GDX | |
|---|---|---|
Market Cap | $112.49B | $25.65B |
Volume | 8,467,392 | 20,709,928 |
Sector | Health | — |
52-Week High | $110.60 | $115.84 |
52-Week Low | $70.08 | $68.28 |
Typical Hold Time | 83 Days | 76 Days |
Enterprise Value | $174.83B | — |
Dividend Yield | 3.02% | — |
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $87.80, up 1.59% today, with strong analyst support (85% buy ratings) and a $111.20 consensus price target suggesting 27% upside. Recent quarterly earnings have consistently beaten expectations, with Q2 2026 EPS of $2.58 surpassing the $1.87 estimate. Revenue growth remains solid, reaching $402.07B in 2025, though net margins compressed to 1.18%. The technical picture shows bullish momentum with current price near key support at $87.
CVS presents a compelling value opportunity with attractive valuation multiples (P/E 23.21, P/S 0.27) and dividend stability, but faces margin pressure from healthcare cost trends. The stock's upside depends on maintaining earnings momentum amid reimbursement challenges and regulatory scrutiny highlighted in recent legal investigations.
GDX trades at $85.46, down 3.13% today amid a bearish technical signal with 13 of 13 moving averages indicating sell signals. The ETF faces pressure from rising interest rates impacting dividend stocks and metals, with silver's sharp decline highlighting sector weakness. Recent news notes institutional selling by Allworth Financial and HB Wealth Management, though Ameritas Advisory increased its stake. Support sits at $84-$85, with resistance at $86-$87.
The outlook remains cautious due to bearish technicals and macro headwinds, but some analysts see value in gold miners' low valuations. Key risks include interest rate sensitivity and metals volatility, while potential catalysts include gold price stability and institutional accumulation. Investors should weigh technical weakness against long-term diversification benefits.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →The fund normally invests at least 80% of its total assets in common stocks and depositary receipts of companies involved in the gold mining industry. The index is a modified market-capitalization weighted index primarily comprised of publicly traded companies involved in the mining for gold and silver. The fund is non-diversified.
Read more on GDX →